Status:
RECRUITING
DIND in Patients With aSAH : Real World Study
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Aneurysmal Subarachnoid Hemorrhage (aSAH)
Eligibility:
All Genders
18-90 years
Brief Summary
In recent years, with the active application of clinical monitoring and treatment methods, the survival rate of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved, but still a certain...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Primary diagnosis of subarachnoid hemorrhage due to rupture of a cerebral artery aneurysm confirmed by cerebral angiotomography or intracranial vessel angiography, requiring admission to the Intensive Care Unit (ICU).
- Signature of the Informed Consent Form for participation in the study in accordance with local applicable regulations.
Exclusion
- Age \< 18 years old
- Primary diagnosis of subarachnoid hemorrhage withouth a visible aneurysm, i.e., post-traumatic or caused by an arteriovenous malformation or bleeding from a brain tumor.
Key Trial Info
Start Date :
September 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT07160088
Start Date
September 3 2025
End Date
December 31 2027
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of neurosurgery, Xuanwu hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053